EVALUATION-MANAGEMENT OF BLADDER CANCER PATIENTS

合作临床研究工作的目标是提高 不同护理方法对膀胱癌患者的护理研究 临床管理方面。 这些研究是根据 精心设计的协议。 中央病理学实验室负责 统一收集、分类和分析病理和 细胞学材料。 统计协调中心负责 数据收集、组织和分析，行政中心是 负责项目的协调和控制。 在每个参与 机构，具体目标是：1。评估和描述所有 膀胱癌患者，他们的肿瘤，以及来自哪些领域 肿瘤出现; 2.研究全身化疗对 转移性膀胱癌; 3.研究全身化疗作为 辅助术前放疗和化疗， 浸润性膀胱癌; 4.研究联合放射治疗和 不能手术的浸润性膀胱癌患者的化疗;以及 5.探讨浅表性膀胱的膀胱灌注治疗 癌

The objective of the collaborative clinical research effort is to improve the care of patients with bladder carcinoma through studies of different aspects of clinical management. The studies are carried out according to well-designed protocols. A Central Pathology Laboratory is responsible for the uniform collection, classification and analysis of pathologic and cytologic material. A Statistical Coordinating Center is responsible for data collection, organization and analyses and the Administrative Center is responsible for program coordination and control. At each participating institution, the specific aims are: 1. To assess and characterize all patients with bladder cancer, their neoplasms, and the fields from which the neoplasm arise; 2. To study systemic chemotherapy in patients with metastatic bladder carcinoma; 3. To study systemic chemotherapy as an adjuvant to preoperative radiotherapy and cystectomy in patients with invasive bladder carcinoma; 4. To study combined radiotherapy and chemotherapy in patients with inoperable, invasive bladder carcinoma; and 5. To study intravesical therapy in patients with superficial bladder cancer.